OSR Health Provides Shareholder Update Following Nasdaq Panel Decision

Nasdaq's Hearings Panel determined on October 23, 2026 to delist OSR Health for failure to maintain the $1.00 minimum bid price; shares have traded OTC since Nasdaq suspended trading on August 26. Management chose not to pursue a reverse split during the compliance process and is now evaluating options to regain a national exchange listing, with a further update promised on or before November 6. The company's $15 million equity put option from BCM Europe AG for VXM01 remains in place and, as amended October 15, can be settled via convertible notes at fixed conversion prices of roughly $2.00-$5.00 per share.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.